These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 22932468)
1. [Lynch syndrome-related endometrial carcinoma]. Pang SJ; Guo DH Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):494-7. PubMed ID: 22932468 [No Abstract] [Full Text] [Related]
2. Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40years of age and younger. Shih KK; Garg K; Levine DA; Kauff ND; Abu-Rustum NR; Soslow RA; Barakat RR Gynecol Oncol; 2011 Oct; 123(1):88-94. PubMed ID: 21742371 [TBL] [Abstract][Full Text] [Related]
3. [Recent advances and future development on Lynch syndrome-associated endometrial cancer]. Ning Y; Wang Y; Wang YY; Zheng WX Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):505-8. PubMed ID: 24246913 [No Abstract] [Full Text] [Related]
4. MMR deficiency is common in high-grade endometrioid carcinomas and is associated with an unfavorable outcome. Nelson GS; Pink A; Lee S; Han G; Morris D; Ogilvie T; Duggan MA; Köbel M Gynecol Oncol; 2013 Nov; 131(2):309-14. PubMed ID: 23938375 [TBL] [Abstract][Full Text] [Related]
5. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset. Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223 [TBL] [Abstract][Full Text] [Related]
6. Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy. Warrier SK; Trainer AH; Lynch AC; Mitchell C; Hiscock R; Sawyer S; Boussioutas A; Heriot AG Dis Colon Rectum; 2011 Dec; 54(12):1480-7. PubMed ID: 22067175 [TBL] [Abstract][Full Text] [Related]
7. Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patients. Walsh MD; Cummings MC; Buchanan DD; Dambacher WM; Arnold S; McKeone D; Byrnes R; Barker MA; Leggett BA; Gattas M; Jass JR; Spurdle AB; Young J; Obermair A Clin Cancer Res; 2008 Mar; 14(6):1692-700. PubMed ID: 18310315 [TBL] [Abstract][Full Text] [Related]
8. In Lynch syndrome adenomas, loss of mismatch repair proteins is related to an enhanced lymphocytic response. Meijer TW; Hoogerbrugge N; Nagengast FM; Ligtenberg MJ; van Krieken JH Histopathology; 2009 Oct; 55(4):414-22. PubMed ID: 19817892 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemistry for mismatch repair protein deficiency in endometrioid endometrial carcinoma yields equivalent results when performed on endometrial biopsy/curettage or hysterectomy specimens. Chapel DB; Yamada SD; Cowan M; Lastra RR Gynecol Oncol; 2018 Jun; 149(3):570-574. PubMed ID: 29656794 [TBL] [Abstract][Full Text] [Related]
10. Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variables. Joehlin-Price AS; Perrino CM; Stephens J; Backes FJ; Goodfellow PJ; Cohn DE; Suarez AA Gynecol Oncol; 2014 Apr; 133(1):43-7. PubMed ID: 24444820 [TBL] [Abstract][Full Text] [Related]
11. Tumor Screening and DNA Testing in the Diagnosis of Lynch Syndrome. Usha L; Dewdney SB; Buckingham LE JAMA; 2016 Jul; 316(1):93-4. PubMed ID: 27380347 [No Abstract] [Full Text] [Related]
12. Screening to detect Lynch syndrome and prevent hereditary cancers in relatives. Haddow JE; Palomaki GE J Med Screen; 2011; 18(4):167-8. PubMed ID: 22184732 [No Abstract] [Full Text] [Related]
13. Lynch syndrome in women less than 50 years of age with endometrial cancer. Matthews KS; Estes JM; Conner MG; Manne U; Whitworth JM; Huh WK; Alvarez RD; Straughn JM; Barnes MN; Rocconi RP Obstet Gynecol; 2008 May; 111(5):1161-6. PubMed ID: 18448750 [TBL] [Abstract][Full Text] [Related]
14. Interobserver variability in the evaluation of mismatch repair protein immunostaining. Klarskov L; Ladelund S; Holck S; Roenlund K; Lindebjerg J; Elebro J; Halvarsson B; von Salomé J; Bernstein I; Nilbert M Hum Pathol; 2010 Oct; 41(10):1387-96. PubMed ID: 20573374 [TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer. Backes FJ; Leon ME; Ivanov I; Suarez A; Frankel WL; Hampel H; Fowler JM; Copeland LJ; O'Malley DM; Cohn DE Gynecol Oncol; 2009 Sep; 114(3):486-90. PubMed ID: 19515405 [TBL] [Abstract][Full Text] [Related]
16. Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries. Ryan P; Mulligan AM; Aronson M; Ferguson SE; Bapat B; Semotiuk K; Holter S; Kwon J; Kalloger SE; Gilks CB; Gallinger S; Pollett A; Clarke BA Cancer; 2012 Feb; 118(3):681-8. PubMed ID: 21721000 [TBL] [Abstract][Full Text] [Related]
17. Significant frequency of MSH2/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas. Rambau PF; Duggan MA; Ghatage P; Warfa K; Steed H; Perrier R; Kelemen LE; Köbel M Histopathology; 2016 Aug; 69(2):288-97. PubMed ID: 26799366 [TBL] [Abstract][Full Text] [Related]
18. Role of endometrial cancer abnormal MMR protein in screening Lynch-syndrome families. Long Q; Peng Y; Tang Z; Wu C Int J Clin Exp Pathol; 2014; 7(10):7297-303. PubMed ID: 25400828 [TBL] [Abstract][Full Text] [Related]